Myeloid cell tropism enables MHC-E–restricted CD8 + T cell priming and vaccine efficacy by the RhCMV/SIV vaccine is a research paper published in Science Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 40 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 3P51OD011092-55S1
SUPPORT FOR NATIONAL PRIMATE RESEARCH CENTER
National Institutes of Health
Grant: 5UM1AI124377-02
Consortia for Innovative AIDS Research in Nonhuman Primates
National Institutes of Health
Grant: 5U19AI128741-05
Development of Immunogenicity- and Efficacy-Optimized CMV Vectors for an HIV/AIDS Vaccine
Fields of Study
Keywords
Sustainable Development Goals